Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-132841)

Filing Details

Accession Number:: 0001104659-16-132841
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-15 17:22:12
Reporting Period:: 2016-07-14

Filing Date:: 2016-07-15
Accepted Time:: 2016-07-15 17:22:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356576	Supernus Pharmaceuticals Inc	SUPN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219844	S Gregory Patrick	C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850	Vp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-07-14	3,395	$22.00	5,616	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015, as amended May 9, 2016.
Includes an aggregate of 930 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.